The application of benchmark dose methodology to data from prenatal developmental toxicity studies

Toxicology Letters
C A KimmelE M Faustman

Abstract

The benchmark dose (BMD) concept was applied to 246 prenatal-developmental toxicity (DT) datasets from government, industry and commercial laboratories. Five modeling approaches were used, 2 generic and 3 specific to DT models. BMDs for both quantal and continuous data were compared with statistically derived no observed adverse effect levels (NOAELs) to determine similarities. Quantal (Q) endpoints included litter responses (e.g., one or more dead or malformed implants), and QBMDs were calculated using a Q Weibull (QW) model. Two types of continuous (C) data were modeled, the proportion of implants affected per litter, and the change in fetal weight (both mean and distribution); continuous power (CP) and DT models were used to calculate CBMDs. QBMDs for a 5% change in response (QBMD05) were 6-fold lower, on average, than the corresponding NOAEL. CBMD05s on average were similar to the corresponding NOAELs, and CBMD05s from different models were similar to each other. Including litter size but not threshold improved the fit of the DT models. For fetal weight data, specific cutoff values were used to calculate BMDs that were similar on average to the corresponding NOAELs: (1) changes from the control mean (5% of the mean, 25th pe...Continue Reading

References

Dec 1, 1991·Risk Analysis : an Official Publication of the Society for Risk Analysis·R L KodellD W Gaylor
Oct 1, 1984·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·K S Crump
Jun 1, 1996·Risk Analysis : an Official Publication of the Society for Risk Analysis·R J KavlockR W Setzer

❮ Previous
Next ❯

Citations

May 31, 2001·Environmental Toxicology and Pharmacology·S DekkersM A.J. Rennen
Jan 13, 1998·American Industrial Hygiene Association Journal·D J Paustenbach
Apr 2, 1998·Risk Analysis : an Official Publication of the Society for Risk Analysis·J A MurrellR W Morris
Feb 6, 2016·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·L David Wise
Nov 5, 2005·Risk Analysis : an Official Publication of the Society for Risk Analysis·Walter W Piegorsch, R Webster West
Dec 17, 2008·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Susan L MakrisBabasaheb Sonawane
Mar 22, 2001·Regulatory Toxicology and Pharmacology : RTP·L A GephartM Pelekis
Dec 28, 2007·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Julia M GohlkeElaine M Faustman
Feb 11, 2005·Journal of Biopharmaceutical Statistics·Walter W PiegorschRalph L Kodell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Toxicology and Applied Pharmacology
A M AmbroseG R Hennigar
Risk Analysis : an Official Publication of the Society for Risk Analysis
J A MurrellR W Morris
Toxicology and Applied Pharmacology
P S LarsonJ F Borzelleca
© 2021 Meta ULC. All rights reserved